Drugs / Lactobacillus rhamnosus X253
Lactobacillus rhamnosus X253
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05123651 | Nov 2020 → Feb 2021 | dental caries | Junlebao Dairy Group Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lactobacillus rhamnosus X253 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05123651 ↗ |
| Known as | Junlebao Lr. X253 | “A Randomized, Double-blinded, Parallel, Placebo-controlled Study to Investigate the Efficacy of Lb Rhamnosus [Junlebao Lr. X253] as Oral Probiotics” NCT05123651 ↗ |
| Known as | L.r X253 | “identical X253 Probiotic lozenge(containing active L.r X253).” NCT05123651 ↗ |
| Known as | Lb Rhamnosus | “A Randomized, Double-blinded, Parallel, Placebo-controlled Study to Investigate the Efficacy of Lb Rhamnosus [Junlebao Lr. X253] as Oral Probiotics” NCT05123651 ↗ |
| Modality | Other / unclassified | “as oral probiotics” NCT05123651 ↗ |
| Route | Oral | “Put the tablet in the mouth and keep it in the mouth for at least 2-3 minutes before swallowing.” NCT05123651 ↗ |